View Item 

Show simple item record

Combined neuropathological pathways account for ageâ related risk of dementia
dc.contributor.authorPower, Melinda C.
dc.contributor.authorMormino, Elizabeth
dc.contributor.authorSoldan, Anja
dc.contributor.authorJames, Bryan D.
dc.contributor.authorYu, Lei
dc.contributor.authorArmstrong, Nicole M.
dc.contributor.authorBangen, Katherine J.
dc.contributor.authorDelano‐wood, Lisa
dc.contributor.authorLamar, Melissa
dc.contributor.authorLim, Yen Ying
dc.contributor.authorNudelman, Kelly
dc.contributor.authorZahodne, Laura
dc.contributor.authorGross, Alden L.
dc.contributor.authorMungas, Dan
dc.contributor.authorWidaman, Keith F.
dc.contributor.authorSchneider, Julie
dc.date.accessioned2018-09-04T20:08:57Z
dc.date.available2019-09-04T20:15:39Zen
dc.date.issued2018-07
dc.identifier.citationPower, Melinda C.; Mormino, Elizabeth; Soldan, Anja; James, Bryan D.; Yu, Lei; Armstrong, Nicole M.; Bangen, Katherine J.; Delano‐wood, Lisa ; Lamar, Melissa; Lim, Yen Ying; Nudelman, Kelly; Zahodne, Laura; Gross, Alden L.; Mungas, Dan; Widaman, Keith F.; Schneider, Julie (2018). "Combined neuropathological pathways account for ageâ related risk of dementia." Annals of Neurology 84(1): 10-22.
dc.identifier.issn0364-5134
dc.identifier.issn1531-8249
dc.identifier.urihttps://hdl.handle.net/2027.42/145549
dc.publisherSage
dc.publisherWiley Periodicals, Inc.
dc.titleCombined neuropathological pathways account for ageâ related risk of dementia
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPsychiatry
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145549/1/ana25246_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145549/2/ana25246.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145549/3/ana25246-sup-0001-suppinfo.pdf
dc.identifier.doi10.1002/ana.25246
dc.identifier.sourceAnnals of Neurology
dc.identifier.citedreferenceSchneider JA, Arvanitakis Z, Yu L, et al. Cognitive impairment, decline and fluctuations in older communityâ dwelling subjects with Lewy bodies. Brain 2012; 135 ( pt 10 ): 3005 â 3014.
dc.identifier.citedreferenceNelson PT, Schmitt FA, Lin Y, et al. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 2011; 134 ( pt 5 ): 1506 â 1518.
dc.identifier.citedreferenceJosephs KA, Whitwell JL, Knopman DS, et al. Abnormal TDPâ 43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 2008; 70 ( 19 pt 2 ): 1850 â 1857.
dc.identifier.citedreferenceBennett DA, Schneider JA, Arvanitakis Z, Wilson RS. Overview and findings from the religious orders study. Curr Alzheimer Res 2012; 9: 628 â 645.
dc.identifier.citedreferenceBennett DA, Schneider JA, Buchman AS, et al. Overview and findings from the Rush Memory and Aging Project. Curr Alzheimer Res 2012; 9: 646 â 663.
dc.identifier.citedreferenceBarnes LL, Shah RC, Aggarwal NT, Bennett DA, Schneider JA. The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementia. Curr Alzheimer Res 2012; 9: 734 â 745.
dc.identifier.citedreferenceMcKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDSâ ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34: 939 â 944.
dc.identifier.citedreferenceRoman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDSâ AIREN International Workshop. Neurology 1993; 43: 250 â 260.
dc.identifier.citedreferenceBennett DA, Schneider JA, Aggarwal NT, et al. Decision rules guiding the clinical diagnosis of Alzheimer’s disease in two communityâ based cohort studies compared to standard practice in a clinicâ based cohort study. Neuroepidemiology 2006; 27: 169 â 176.
dc.identifier.citedreferenceMcKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 1999; 53: 902 â 905.
dc.identifier.citedreferenceBoyle PA, Wilson RS, Yu L, et al. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol 2013; 74: 478 â 489.
dc.identifier.citedreferenceBoyle PA, Yang J, Yu L, et al. Varied effects of ageâ related neuropathologies on the trajectory of late life cognitive decline. Brain 2017; 140: 804 â 812.
dc.identifier.citedreferenceMcKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996; 47: 1113 â 1124.
dc.identifier.citedreferenceBrowne M, Cudeck R. Alternative ways of assessing model fit. In: Bollen K, Long J, eds. Testing Structural Equation Models. Newbury Park, CA: Sage; 1993: 136 â 162.
dc.identifier.citedreferenceWidaman KF, Reise SP. Exploring the measurement invariance of psychological instruments: Applications in the substance use domain. The science of prevention: methodological advances from alcohol and substance abuse research. Washington, DC: American Psychological Association; 1997: 281 â 324.
dc.identifier.citedreferenceMuthén LK, Muthén BO. Mplus User’s Guide, 8th ed. Los Angeles, CA: Muthén & Muthén; 1998â 2017.
dc.identifier.citedreferenceSchneider JA, Boyle PA, Arvanitakis Z, Bienias JL, Bennett DA. Subcortical infarcts, Alzheimer’s disease pathology, and memory function in older persons. Ann Neurol 2007; 62: 59 â 66.
dc.identifier.citedreferenceTroncoso JC, Zonderman AB, Resnick SM, et al. Effect of infarcts on dementia in the Baltimore Longitudinal Study of Aging. Ann Neurol 2008; 64: 168 â 176.
dc.identifier.citedreferenceSonnen JA, Larson EB, Crane PK, et al. Pathological correlates of dementia in a longitudinal, populationâ based sample of aging. Ann Neurol 2007; 62: 406 â 413.
dc.identifier.citedreferenceYu L, Boyle PA, Leurgans S, Schneider JA, Bennett DA. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging 2014; 35: 819 â 826.
dc.identifier.citedreferenceJosephs KA, Whitwell JL, Weigand SD, et al. TDPâ 43 is a key player in the clinical features associated with Alzheimer’s disease. Acta Neuropathol 2014; 127: 811 â 824.
dc.identifier.citedreferenceNag S, Yu L, Capuano AW, et al. Hippocampal sclerosis and TDPâ 43 pathology in aging and Alzheimer disease. Ann Neurol 2015; 77: 942 â 952.
dc.identifier.citedreferenceIghodaro ET, Jicha GA, Schmitt FA, et al. Hippocampal sclerosis of aging can be segmental: two cases and review of the literature. J Neuropathol Exp Neurol 2015; 74: 642 â 652.
dc.identifier.citedreferenceGraffâ Radford NR, Besser LM, et al. Neuropathological differences by race from the National Alzheimer’s Coordinating Center. Alzheimers Dement 2016; 12: 669 â 677.
dc.identifier.citedreferenceWilkins CH, Grant EA, Schmitt SE, McKeel DW, Morris JC. The neuropathology of Alzheimer disease in African American and white individuals. Arch Neurol 2006; 63: 87 â 90.
dc.identifier.citedreferenceSandberg G, Stewart W, Smialek J, Troncoso JC. The prevalence of the neuropathological lesions of Alzheimer’s disease is independent of race and gender. Neurobiol Aging 2001; 22: 169 â 175.
dc.identifier.citedreferenceBennett DA, Wilson RS, Schneider JA, et al. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer’s disease. Neurology 2003; 60: 246 â 252.
dc.identifier.citedreferenceKasanuki K, Heckman MG, Diehl NN, et al. Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease. Mov Disord 2017; 32: 1584 â 1593.
dc.identifier.citedreferenceMungas D, Tractenberg R, Schneider JA, Crane PK, Bennett DA. A 2â process model for neuropathology of Alzheimer’s disease. Neurobiol Aging 2014; 35: 301 â 308.
dc.identifier.citedreferenceSuemoto CK, Ferrettiâ Rebustini RE, Rodriguez RD, et al. Neuropathological diagnoses and clinical correlates in older adults in Brazil: a crossâ sectional study. PLoS Med 2017; 14: e1002267.
dc.identifier.citedreferenceTanskanen M, Makela M, Notkola IL, et al. Populationâ based analysis of pathological correlates of dementia in the oldest old. Ann Clin Transl Neurol 2017; 4: 154 â 165.
dc.identifier.citedreferenceWhite LR, Edland SD, Hemmy LS, et al. Neuropathologic comorbidity and cognitive impairment in the Nun and Honoluluâ Asia Aging Studies. Neurology 2016; 86: 1000 â 1008.
dc.identifier.citedreferenceSchneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in communityâ dwelling older persons. Neurology 2007; 69: 2197 â 2204.
dc.identifier.citedreferenceRahimi J, Kovacs GG. Prevalence of mixed pathologies in the aging brain. Alzheimers Res Ther 2014; 6: 82.
dc.identifier.citedreferenceJellinger KA, Attems J. Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm (Vienna) 2015; 122: 505 â 521.
dc.identifier.citedreferenceJames BD, Wilson RS, Boyle PA, et al. TDPâ 43 stage, mixed pathologies, and clinical Alzheimer’sâ type dementia. Brain 2016; 139: 2983 â 2993.
dc.identifier.citedreferenceKapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol 2017; 134: 171 â 186.
dc.identifier.citedreferenceKawas CH, Kim RC, Sonnen JA, et al. Multiple pathologies are common and related to dementia in the oldestâ old: The 90â +â Study. Neurology 2015; 85: 535 â 542.
dc.identifier.citedreferenceCorrada MM, Berlau DJ, Kawas CH. A populationâ based clinicopathological study in the oldestâ old: The 90â +â Study. Curr Alzheimer Res 2012; 9: 709 â 717.
dc.identifier.citedreferencePathological correlates of lateâ onset dementia in a multicentre, communityâ based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001; 357: 169 â 175.
dc.identifier.citedreferenceSnowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997; 277: 813 â 817.
dc.identifier.citedreferenceCorrada MM, Sonnen JA, Kim RC, Kawas CH. Microinfarcts are common and strongly related to dementia in the oldestâ old: The 90â +â Study. Alzheimers Dement 2016; 12: 900 â 908.
dc.identifier.citedreferenceCharidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 2012; 83: 124 â 137.
dc.identifier.citedreferenceCase NF, Charlton A, Zwiers A, et al. Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment. Stroke 2016; 47: 2010 â 2016.
dc.identifier.citedreferenceBoyle PA, Yu L, Nag S, et al. Cerebral amyloid angiopathy and cognitive outcomes in communityâ based older persons. Neurology 2015; 85: 1930 â 1936.
dc.identifier.citedreferenceHamilton RL. Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using alphaâ synuclein immunohistochemistry. Brain Pathol 2000; 10: 378 â 384.
dc.identifier.citedreferenceSchneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol 2009; 66: 200 â 208.
dc.identifier.citedreferenceWalker Z, McKeith I, Rodda J, et al. Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer’s disease: a cohort study. BMJ Open 2012; 2: e000380.
dc.identifier.citedreferenceChung EJ, Babulal GM, Monsell SE, et al. Clinical features of Alzheimer disease with and without Lewy bodies. JAMA Neurol 2015; 72: 789 â 796.
dc.identifier.citedreferenceConnor DJ, Salmon DP, Sandy TJ, et al. Cognitive profiles of autopsyâ confirmed Lewy body variant vs pure Alzheimer disease. Arch Neurol 1998; 55: 994 â 1000.
dc.identifier.citedreferenceAmadorâ Ortiz C, Lin WL, Ahmed Z, et al. TDPâ 43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 2007; 61: 435 â 445.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ana25246_am.pdf
Size:
339.4KB
Format:
PDF
View/Open
Name:
ana25246.pdf
Size:
459.0KB
Format:
PDF
View/Open
Name:
ana25246-sup-0001-suppinfo.pdf
Size:
147.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.